Table 3 Multivariate analysis of prognostic factors for progression-free survival
From: Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Variables | HR (95% CI) | P value |
|---|---|---|
BCLC stage | ||
 C | Reference |  |
 B | 0.551 (0.293, 1.035) | 0.064 |
Tumor number | ||
  = 1 | Reference |  |
  ≥ 2 | 0.601 (0.325, 1.110) | 0.104 |
NLR | 0.802 (0.657, 0.980) | 0.031 |